Groups | Model 1 | Â | Model 2 | Â | Model 3 | Â |
---|---|---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | |
All patients | ||||||
SHR, per 0.1 increase | 1.06 (0.97-1.16) | 0.19 | 0.96 (0.87-1.05) | 0.38 | 0.96 (0.87-1.06) | 0.43 |
SHR tertiles | ||||||
 T1 (<0.753) | 1.89 (0.79-4.50) | 0.15 | 3.71 (1.45-9.51) | 0.01 | 3.33 (1.28-8.73) | 0.01 |
 T2 (0.753-0.895) | Ref |  | Ref |  | Ref |  |
 T3 (>0.895) | 3.66 (1.67-8.05) | 0.001 | 2.97 (1.29-6.81) | 0.01 | 2.72 (1.17-6.36) | 0.02 |
HbA1c <6.5% | ||||||
SHR, per 0.1 increase | 1.12 (0.98-1.28) | 0.11 | 1.00 (0.86-1.18) | 0.96 | 1.01 (0.87-1.18) | 0.88 |
SHR tertiles | ||||||
 T1 (<0.754) | 1.39 (0.48-4.00) | 0.55 | 3.65 (1.11-11.97) | 0.03 | 3.34 (0.97-11.49) | 0.05 |
 T2 (0.754-0.893) | Ref |  | Ref |  | Ref |  |
 T3 (>0.893) | 2.94 (1.16-7.45) | 0.02 | 3.13 (1.13-8.72) | 0.03 | 2.96 (1.04-8.41) | 0.04 |